Open original FDA record ↗Recall record
- FDA identifier
- Z-1043-2017
- Company in FDA record
- The Binding Site Group, Ltd.
- FDA classification date
- Jan 18, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Batch numbers listed are reporting Lambda Free Light Chain results >114mg/L that are on average 33% lower than other Optilite Lambda Freelite batches. Therefore users moving to this batch will see results >114mg/L giving lower results and conversely when switching to the next batch results will be seen to shift upwards.
Source facts
- Action
- On 07/05/16 notification letters were sent to customers. The Binding Site Group requests the following: - Immediately Quarantine & Dispose of any LK018.OPT lot 405566 kits within stock; - Remove any affected lots from the Optilite instrument; - Patients with Lambda Freelite results >114mg/L should be reviewed in consultation with clinicians, alongside other clinical findings and retested where applicable; - Notify local Binding Site representative to request replacement kits; - Return completed E-Back Form to local Binding Site Representative; The firm recommended that the notice be circulated to those within the organization who need to be aware.
- Initiated
- 2016-07-05
- Root cause
- Under Investigation by firm
- Terminated
- 2017-07-03
- Distribution
- U.S. distribution to the following; AR, PA, GA, NC, KY, VA, CA. Foreign distribution to the following; Uk, Germany, France, Italy, Spain, Czech Republic, Portugal, Belgium.
- Recall number
- Z-1043-2017
- Recall status
- Terminated
- CDRH record ID
- 152050
- FDA classified
- 2017-01-18
- Recall event number
- 76048